Search results
Results From The WOW.Com Content Network
Respiratory pressure meter. Measuring respiratory muscle strength is a long-established method of assessing the mechanics of breathing. Respiratory muscle dysfunction (i.e., reduced strength or endurance) should be distinguished from lung function abnormalities and measured separately.
Other tests may be performed in certain situations. Results are usually given in both raw data (litres, litres per second) and percent predicted—the test result as a percent of the "predicted values" for the patients of similar characteristics (height, age, sex, and sometimes race and weight).
However, the PSI is more complicated and requires arterial blood gas sampling amongst other tests; given this, the CURB-65 score is more easily used in primary care settings. [7] A variant of the CURB-65 that omits the urea measurement (CRB-65) [ 7 ] is even simpler, as it relies only on history and examination findings rather than blood tests.
After obtaining the patient's respiratory rate, the examiner looks for any signs of respiratory distress, which may include: Cyanosis, a bluish tinge of the extremities (peripheral cyanosis), or of tongue (central cyanosis) [4] Pursed-lip breathing [5] Accessory muscle use, including the scalene and intercostal muscles [5]
The interpretation of tests depends on comparing the patients values to published normals from previous studies. Deviation from guidelines can result in false-positive or false negative test results, even though only a small minority of pulmonary function laboratories followed published guidelines for spirometry, lung volumes and diffusing ...
(Reuters) -Merck said on Thursday it had discontinued a trial testing a combination immunotherapy treatment in patients with a type of lung cancer after an interim analysis showed the drug was ...
The first edition of The Merck Manual was published in 1899 by Merck & Co., Inc. for physicians and pharmacists and was titled Merck's Manual of the Materia Medica. [6] [7] The 192 page book which sold for US $1.00, was divided into three sections, Part I ("Materia Medica") was an alphabetical listing of all known compounds thought to be of therapeutic value with uses and doses; Part II ...
Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by chronic respiratory symptoms and airflow limitation. [8] GOLD 2024 defined COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea or shortness of breath, cough, sputum production or exacerbations) due to abnormalities of the airways (bronchitis ...